BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12915590)

  • 1. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization.
    Kurki S; Latonen L; Laiho M
    J Cell Sci; 2003 Oct; 116(Pt 19):3917-25. PubMed ID: 12915590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
    Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
    Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
    Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.
    Khan S; Guevara C; Fujii G; Parry D
    Oncogene; 2004 Aug; 23(36):6040-6. PubMed ID: 15195142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PML enhances the regulation of p53 by CK1 in response to DNA damage.
    Alsheich-Bartok O; Haupt S; Alkalay-Snir I; Saito S; Appella E; Haupt Y
    Oncogene; 2008 Jun; 27(26):3653-61. PubMed ID: 18246126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARF function does not require p53 stabilization or Mdm2 relocalization.
    Korgaonkar C; Zhao L; Modestou M; Quelle DE
    Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
    Louria-Hayon I; Grossman T; Sionov RV; Alsheich O; Pandolfi PP; Haupt Y
    J Biol Chem; 2003 Aug; 278(35):33134-41. PubMed ID: 12810724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and functional interactions between PML and MDM2.
    Wei X; Yu ZK; Ramalingam A; Grossman SR; Yu JH; Bloch DB; Maki CG
    J Biol Chem; 2003 Aug; 278(31):29288-97. PubMed ID: 12759344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53.
    Zhu H; Wu L; Maki CG
    J Biol Chem; 2003 Dec; 278(49):49286-92. PubMed ID: 14507915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways.
    Zhao L; Samuels T; Winckler S; Korgaonkar C; Tompkins V; Horne MC; Quelle DE
    Mol Cancer Res; 2003 Jan; 1(3):195-206. PubMed ID: 12556559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
    Llanos S; Clark PA; Rowe J; Peters G
    Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MDM2-p53 interaction.
    Moll UM; Petrenko O
    Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction.
    Latonen L; Kurki S; Pitkänen K; Laiho M
    Cell Signal; 2003 Jan; 15(1):95-102. PubMed ID: 12401524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
    Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
    J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation.
    Zhou BP; Liao Y; Xia W; Zou Y; Spohn B; Hung MC
    Nat Cell Biol; 2001 Nov; 3(11):973-82. PubMed ID: 11715018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair.
    Alt JR; Bouska A; Fernandez MR; Cerny RL; Xiao H; Eischen CM
    J Biol Chem; 2005 May; 280(19):18771-81. PubMed ID: 15734743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
    Kulikov R; Boehme KA; Blattner C
    Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.